Refining How We Diagnose and Classify Limbal Stem Cell deficiency

Area of Science:

• Ophthalmology
• Regenerative Medicine
• Ocular Surface Disease

Background:

• Limbal stem cell deficiency (LSCD) diagnosis has historically relied on subjective methods like fluorescein staining.
• Understanding LSCD pathophysiology and presentation is crucial for effective management.
• Comorbidities significantly impact limbal stem cell (LSC) function and ocular surface health.

Purpose of the Study:

• To refine the diagnosis and classification of LSCD.
• To establish a comprehensive algorithm for evaluating the ocular surface environment in LSCD.
• To improve the staging of LSCD using multimodal diagnostic tools.

Main Methods:

• Review of relevant publications on LSCD diagnosis and staging.
• Analysis of clinical presentation and pathophysiology of LSCD.
• Discussion of factors affecting LSC function and survival.

Main Results:

• The International LSCD Working Group has proposed new guidelines for LSCD definition, classification, diagnosis, staging, and management.
• Multimodal anterior segment imaging (e.g., OCT, confocal microscopy) allows objective evaluation of corneal and limbal microstructure.
• Impression cytology remains valuable for assessing conjunctivalization and epithelial phenotype.

Conclusions:

• LSCD diagnosis has evolved beyond fluorescein staining, incorporating objective imaging and molecular testing.
• A standardized multimodal diagnostic framework enhances diagnostic accuracy and guides LSCD management.
• This framework supports the development and evaluation of novel regenerative therapies for LSCD.